儿童重症监护中接受体外膜氧合、心室辅助装置和肾脏替代治疗患儿的红细胞输注指征推荐
该共识由38名国际多学科专家组成的小组制定,其中ECMO/VAD/RRT亚组6人,检索PubMed、EMBASE和Cochrane Library(1980年至2017年5月)并采用GRADE系统分级证据。针对接受ECMO、VAD或RRT的住院患儿,专家达成>80%一致同意5条良好实践声明(旨在提高红细胞输注数据报告的准确性和统一性)、4条临床推荐(除血红蛋白浓度外,使用氧输送的生理指标和生物标志物指导红细胞输注,同时承认证据不足以推荐具体输注策略)和8条研究推荐。结论认为,目前证据不足以推荐接受这些体外支持患儿的具体红细胞输注变量,需进一步研究输注指征、风险、获益和替代方案。
要点
- 专家小组一致同意(>80%)5条良好实践声明,旨在提高儿童ECMO、VAD和RRT研究中红细胞输注数据报告的准确性和统一性。
- 4条临床推荐建议除血红蛋白浓度外,使用氧输送的生理指标和生物标志物指导红细胞输注决策。
- 专家小组承认目前证据不足以推荐接受ECMO、VAD或RRT患儿的具体红细胞输注策略。
- 提出8条研究推荐,强调需进一步研究这些患儿红细胞输注的指征、风险、获益和替代方案。
- 证据分级采用GRADE系统,推荐达成采用Research and Development/UCLA Appropriateness Method。
适用人群与场景
- 接受体外膜氧合(ECMO)、心室辅助装置(VAD)或肾脏替代治疗(RRT)支持的危重住院患儿。
处置流程与药物剂量
- 临床推荐:除血红蛋白浓度外,使用氧输送的生理指标和生物标志物指导红细胞输注(证据不足以推荐具体输注策略)。
研究设计与关键结果
- 共识会议系列由38名国际多学科专家参与,其中ECMO/VAD/RRT亚组6名专家。
- 检索PubMed、EMBASE和Cochrane Library数据库1980年至2017年5月,使用标准化数据提取表构建证据表,采用GRADE系统分级证据。
- 针对接受ECMO、VAD或RRT的住院患儿,专家一致同意(>80%)5条良好实践声明,旨在提高红细胞输注数据报告的准确性和统一性。
- 达成4条临床推荐:除血红蛋白浓度外,使用氧输送的生理指标和生物标志物指导红细胞输注,同时承认证据不足以推荐具体红细胞输注策略。
- 提出8条研究推荐。
- 结论:目前证据不足以推荐接受ECMO、VAD或RRT患儿的具体红细胞输注变量。
证据类型、等级与局限
- 证据类型:国际多学科专家共识会议,采用GRADE系统分级证据,推荐达成采用Research and Development/UCLA Appropriateness Method。
- 专家一致同意程度>80%。
- 局限:原文未报告局限性
对床旁实践的改变
- 作者认为,对于接受ECMO、VAD或RRT的危重患儿,除血红蛋白浓度外,可考虑使用氧输送的生理指标和生物标志物指导红细胞输注决策(临床推荐,证据不足以推荐具体策略)。
- 作者认为,目前证据不足以推荐该人群的具体红细胞输注策略,需进一步研究输注指征、风险、获益和替代方案。
指南或共识出处
- Pediatric Critical Care Transfusion and Anemia Expertise Initiative(儿童重症输血与贫血专家倡议组)发布的推荐,发表于Pediatric Critical Care Medicine。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To present recommendations and supporting literature for RBC transfusions in critically ill children supported with extracorporeal membrane oxygenation, ventricular assist devices, or renal replacement therapy.
DESIGN: Consensus conference series of international, multidisciplinary experts in RBC transfusion management of critically ill children.
METHODS: The panel of 38 experts developed evidence-based, and when evidence was lacking, expert-based clinical recommendations as well as research priorities for RBC transfusions in critically ill children. The extracorporeal membrane oxygenation/ventricular assist device/renal replacement therapy subgroup included six experts. We conducted electronic searches of the PubMed, EMBASE, and Cochrane Library databases from 1980 to May 2017, using medical subject heading terms and text words to define concepts of RBC transfusion, extracorporeal membrane oxygenation, ventricular assist device, and renal replacement therapy. We used a standardized data extraction form to construct evidence tables and graded the evidence using the Grading of Recommendations Assessment, Development, and Evaluation system. Recommendations developed and supporting literature were reviewed and scored by all panel members. Agreement was obtained using the Research and Development/UCLA Appropriateness Method.
RESULTS: For inpatients requiring extracorporeal membrane oxygenation, ventricular assist device, or renal replacement therapy support, there was expert agreement (> 80%) on five good practice statements aimed to improve accuracy and uniform reporting of RBC transfusion data in pediatric extracorporeal membrane oxygenation, ventricular assist device, and renal replacement therapy studies and quality improvement projects; four clinical recommendations of physiologic metrics and biomarkers of oxygen delivery, in addition to hemoglobin concentration, to guide RBC transfusion, acknowledging insufficient evidence to recommend specific RBC transfusion strategies; and eight research recommendations.
CONCLUSIONS: Further research surrounding indications, risks, benefits, and alternatives to RBC transfusion in children on extracorporeal devices is clearly needed. Using a structured literature review and grading process, the Transfusion and Anemia Expertise Initiative panel concluded that there is currently insufficient evidence to recommend specific RBC transfusion variables in children requiring extracorporeal membrane oxygenation, ventricular assist device, or renal replacement therapy support.
参考来源
- Bembea MM, Cheifetz IM, Fortenberry JD, et al. Recommendations on the Indications for RBC Transfusion for the Critically Ill Child Receiving Support From Extracorporeal Membrane Oxygenation, Ventricular Assist, and Renal Replacement Therapy Devices From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative. Pediatr Crit Care Med. 2018. PMID: 30161071. doi:10.1097/PCC.0000000000001600
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。